Assessment of the Effectiveness of the Thalidomide Celgene Pregnancy Prevention Programme (PPP) in the United Kingdom

被引：0
|
作者：
Witty, J. M.
Thompson, M.
Freeman, J. [1 ]
Bwire, R. [1 ]
机构：
[1] Celgene Corp, Summit, NJ USA
来源：
DRUG SAFETY | 2010年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
19
引用
收藏
页码：901 / 901
页数：1
相关论文
共 48 条
  • [31] Use of surrogate outcomes in cost-effectiveness mode's: A review of United Kingdom health technology assessment reports
    Elston, Julian
    Taylor, Rod S.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 (01) : 6 - 13
  • [32] Transthoracic Echocardiographic Assessment of the Heart in Pregnancy—a position statement on behalf of the British Society of Echocardiography and the United Kingdom Maternal Cardiology Society
    Stephanie L. Curtis
    Mark Belham
    Sadie Bennett
    Rachael James
    Allan Harkness
    Wendy Gamlin
    Baskaran Thilaganathan
    Veronica Giorgione
    Hannah Douglas
    Aisling Carroll
    Jamie Kitt
    Claire Colebourn
    Isabel Ribeiro
    Sarah Fairbairn
    Daniel X. Augustine
    Shaun Robinson
    Sara A. Thorne
    Echo Research & Practice, 10
  • [33] Assessment of the cost-effectiveness of zoledronic acid in the management of skeletal metastases in lung cancer patients in France, Germany, and the United Kingdom
    Botteman, Marc F.
    Kaura, Satyin
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S542 - S543
  • [34] Cost-effectiveness of ventricular assist device use in the United Kingdom: Results from the evaluation of ventricular assist device programme in the UK (EVAD-UK)
    Sharples, Linda D.
    Dyer, Matthew
    Cafferty, Fay
    Demiris, Nikolaos
    Freeman, Carol
    Banner, Nicholas R.
    Large, Stephen R.
    Tsui, Steven
    Caine, Noreen
    Buxton, Martin
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (11): : 1336 - 1343
  • [35] Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study
    Taylor, Douglas C. A.
    Pandya, Ankur
    Thompson, David
    Chu, Paula
    Graff, Jennifer
    Shepherd, James
    Wenger, Nanette
    Greten, Heiner
    Carmena, Rafael
    Drummond, Michael
    Weinstein, Milton C.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2009, 10 (03): : 255 - 265
  • [36] Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study
    Douglas C. A. Taylor
    Ankur Pandya
    David Thompson
    Paula Chu
    Jennifer Graff
    James Shepherd
    Nanette Wenger
    Heiner Greten
    Rafael Carmena
    Michael Drummond
    Milton C. Weinstein
    The European Journal of Health Economics, 2009, 10 : 255 - 265
  • [37] Cost-effectiveness of zoledronic acid in the prevention of fractures in postmenopausal women with early breast cancer receiving aromatase inhibitor: Application to the United Kingdom
    Logman, F.
    Heeg, B.
    Botteman, M. F.
    Marfatia, A. A.
    Van Hout, B. A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 156 - 156
  • [38] Transthoracic Echocardiographic Assessment of the Heart in Pregnancy-a position statement on behalf of the British Society of Echocardiography and the United Kingdom Maternal Cardiology Society
    Curtis, Stephanie L.
    Belham, Mark
    Bennett, Sadie
    James, Rachael
    Harkness, Allan
    Gamlin, Wendy
    Thilaganathan, Baskaran
    Giorgione, Veronica
    Douglas, Hannah
    Carroll, Aisling
    Kitt, Jamie
    Colebourn, Claire
    Ribeiro, Isabel
    Fairbairn, Sarah
    Augustine, Daniel X.
    Robinson, Shaun
    Thorne, Sara A.
    ECHO RESEARCH AND PRACTICE, 2023, 10 (01)
  • [39] COST-EFFECTIVENESS OF BEZLOTOXUMAB plus STANDARD OF CARE (SOC) VERSUS PLACEBO plus SOC FOR THE PREVENTION OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN THE UNITED KINGDOM
    Ahir, H. B.
    Jiang, Y.
    Marcella, S.
    Tiemey, P.
    VALUE IN HEALTH, 2017, 20 (09) : A790 - A790
  • [40] Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom
    Max Kindred
    Zahratu Shabrina
    Neily Zakiyah
    Applied Health Economics and Health Policy, 2024, 22 : 49 - 60
12345